Troxatyl Clinical Trial Is Halted

Posted by rob on August 30, 2006 under Uncategorized | Be the First to Comment

SGX plunges on failed clinical trial
MarketWatch - 16 hours ago
BOSTON (MarketWatch) — Shares of SGX Pharmaceutical plunged over 40% on Tuesday the day after it said it was discontinuing a key clinical trial for its
SGX Shares Dive on Discontinued Study
Houston Chronicle, United States - 16 hours ago
NEW YORK — Shares of drug developer SGX Pharmaceuticals Inc. plunged Tuesday on news the company will shelve a clinical trial
SGX Pharmaceuticals Plummets
TheStreet.com - 18 hours ago
SGX Pharmaceuticals (SGXP – commentary – Cramer’s Take) sank a day after saying it would end a clinical trial of Troxatyl as a third-line treatment for
BIOTECH STOCKS
MarketWatch - 20 hours ago
BOSTON (MarketWatch) — Benchmarks tracking drug and biotechnology stocks were on the rise Tuesday, but shares of SGX Pharmaceuticals plunged as the sector’s
SGX Pharma Discontinues Troxatyl Trial
Houston Chronicle, United States - Aug 28, 2006
SAN DIEGO — SGX Pharmaceuticals Inc. said Monday it discontinued a late stage trial of its lead candidate Troxatyl for certain
UPDATE 1-SGX stops Troxatyl clinical trial, shares tank on Inet
Reuters - Aug 28, 2006
Michael Grey, joined us in September 2001 as our Executive Vice President and Chief Business Officer and as a member of our board of directors. He… Full Bio.
SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial of
Yahoo! News (press release) - Aug 28, 2006
SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ — SGX Pharmaceuticals, Inc. (Nasdaq: SGXP – News) announced today that it has discontinued
SGX Stock Plummets After Troxatyl Fails In Phase II/III
BioWorld Online, GA - 7 hours ago
By Aaron Lorenzo. Shares in SGX Pharmaceuticals Inc. suffered mightily on Tuesday following a Phase II/III study stoppage. An independent
SGX Pharmaceuticals Inc. Fell Below Support On Troxatyl News
Trading Markets, CA - 15 hours ago
(RTTNews) – SGX Pharmaceuticals Inc. (SGXP | charts | news | PowerRating) announced after the close on Monday that it discontinued
SGX Pharma cancels phase III clinical trial
San Diego Daily Transcript (subscription), CA - Aug 28, 2006
By JERAN WITTENSTEIN, The Daily Transcript. San Diego-based SGX Pharmaceuticals Inc. (Nasdaq: SGXP, News) announced Monday it has
SGX Discontinues Phase II/III Clinical Trial Of Troxatyl In Third
Trading Markets, CA - Aug 28, 2006
(RTTNews) – SGX Pharmaceuticals, Inc. (SGXP | charts | news | PowerRating) said Monday that it has discontinued the Phase II/III
SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial Of
Medical News Today (press release), UK - Aug 29, 2006
SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) announced today that it has discontinued the Phase II/III clinical trial of Troxatyl(TM
UPDATE: SGX Plunges On Failed Clinical Trial
Easy Bourse (Communiqués de presse), France - 9 hours ago
By Val Brickates Kennedy. BOSTON (Dow Jones) — Shares of SGX Pharmaceutical plunged over 40% on Tuesday the day after it said it
SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial of
PipelineReview.com (press release), Spain - Aug 29, 2006
SAN DIEGO, CA, USA | Aug 28, 2006 | SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) announced today that it has discontinued the Phase
SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial of
PharmaLive.com (press release), PA - Aug 28, 2006
SAN DIEGO, August 28, 2006 /PRNewswire-FirstCall/ — SGX Pharmaceuticals, Inc. announced today that it has discontinued the Phase
SGX Pharmaceuticals Discontinues Phase II/III Clinical Trial of
PR Newswire (press release), NY - Aug 28, 2006
Conference Call Scheduled for 6:30 pm EDT today SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ — SGX Pharmaceuticals, Inc. (Nasda

Add A Comment

You must be logged in to post a comment.